Aimee M. Banks, PharmD, BCPS, MSCS

Experts debate tracking MS progression beyond EDSS, blending patient-reported symptoms, MRI metrics, and new ICD-10 coding for access.

Experts weigh EDSS vs patient-reported symptoms in SPMS, urging composite endpoints, MRI insights, and smarter coding to improve therapy access.

Explore who drives REMS success—from FDA and manufacturers to pharmacists and patients—and how MS therapy routes shape safety, adherence, and workflow.

Explore emerging multiple sclerosis treatments, from brain-protective targets and remyelination to CAR-T, stem cell transplants, and more accessible anti-CD20 options.

Experts explore emerging multiple sclerosis treatments, from brain-protective PDE4 inhibitors and remyelination to CAR T, stem cell transplant, and easier anti-CD20 options.

Finibrutinib’s phase 3 MS results hint at new hope for relapsing and progressive disease, as experts weigh safety and monitoring.

Why MS relapses aren’t the whole story: experts explain PIRA, the push for remyelination, and how BTK inhibitors may reach the CNS.

MS experts say MRI and current trial endpoints miss “smoldering” progression; emerging biomarkers, 7T imaging, PROs, and CNS-penetrant therapies aim to close gaps.

Learn how hidden neuroinflammation drives MS progression, why MRI may miss it, and how rim lesions and testing track disability.

Learn how diffuse neuroinflammation drives progressive MS, how MRI finds paramagnetic rim lesions, and which cognitive and physical tests track disability over time.

Learn how MRI, OCT, and CSF markers refine MS diagnosis and monitoring, and why “active” disease matters beyond relapses.

Discover the significance of PIRA in multiple sclerosis (MS) and how pharmacists enhance early detection and patient care in MS management.

Explore innovative strategies for identifying and managing multiple sclerosis through expert insights on biomarker-driven care and clinical practices.

Explore how pharmacists enhance access to care for multiple sclerosis patients, tackling barriers in diagnosis, treatment, and patient education.

Pharmacists enhance care for multiple sclerosis patients by improving access, education, and adherence, ensuring effective treatment through collaboration with healthcare teams.